# Liposomal Magnesium L-Threonate - 3-Year Financial Proforma
## DTC Consumer Health Brand

---

## Executive Summary

This financial proforma models a 3-year projection for a DTC liposomal magnesium L-threonate supplement targeting stressed professionals aged 30-50 with household income $75K+.

### Key Highlights

| Metric | Year 1 | Year 2 | Year 3 |
|--------|--------|--------|--------|
| **Revenue** | $1.04M | $5.43M | $13.16M |
| **EBITDA** | -$368K | $427K | $2.88M |
| **Unique Customers** | 10,000 | 40,000 | 100,000 |
| **Gross Margin** | 54.1% | 53.1% | 52.8% |
| **EBITDA Margin** | -35.3% | 7.9% | 21.9% |

**Path to Profitability:** Q2 Year 2 (Month 15-18)
**Funding Required:** $613K minimum ($700-900K recommended)

---

## 1. Unit Economics

### Pricing Structure

| Item | Value |
|------|-------|
| MSRP | $54.00 |
| Subscription Discount | 18% |
| Subscription Price | $44.28 |
| Blended ASP (Y1) | $48.17 |

### COGS Breakdown

| Component | Cost | % of MSRP |
|-----------|------|-----------|
| Raw Materials | $10.00 | 18.5% |
| Manufacturing | $4.00 | 7.4% |
| Packaging | $1.50 | 2.8% |
| Fulfillment | $4.00 | 7.4% |
| Payment Processing | $1.62 | 3.0% |
| **Total COGS** | **$21.12** | **39.1%** |

### Customer Acquisition Cost (CAC) by Channel

| Channel | CAC |
|---------|-----|
| Facebook/Instagram | $42.00 |
| Google Search | $48.00 |
| TikTok | $35.00 |
| Amazon Ads | $28.00 |
| Influencer | $55.00 |
| Organic/Referral | $8.00 |

### Blended CAC (Weighted Average)

| Year | Blended CAC |
|------|-------------|
| Year 1 | $40.65 |
| Year 2 | $38.95 |
| Year 3 | $35.90 |

### Customer Lifetime Value (LTV)

| Metric | Value |
|--------|-------|
| Customer LTV | $176.67 |
| Monthly Churn Rate | 15% |
| LTV:CAC Ratio (Y1) | 4.35x |
| LTV:CAC Ratio (Y3) | 4.92x |
| CAC Payback Period | 2 months |

**Analysis:** The 4.35x LTV:CAC ratio and 2-month payback period are excellent for a DTC subscription business, indicating strong unit economics and capital efficiency.

---

## 2. Three-Year P&L Summary

### Annual Performance

| Metric | Year 1 | Year 2 | Year 3 |
|--------|--------|--------|--------|
| **Unique Customers (end)** | 9,994 | 40,000 | 100,000 |
| **Active Subscribers (end)** | 3,774 | 13,116 | 28,018 |
| **Total Orders** | 22,604 | 120,666 | 294,009 |
| **Revenue** | $1,039,795 | $5,430,609 | $13,164,519 |
| **COGS** | $477,396 | $2,548,466 | $6,209,470 |
| **Gross Profit** | $562,398 | $2,882,143 | $6,955,048 |
| **Gross Margin %** | 54.1% | 53.1% | 52.8% |
| **Marketing Spend** | $467,908 | $1,900,713 | $3,291,130 |
| **Fixed OpEx** | $462,000 | $554,400 | $785,400 |
| **Total OpEx** | $929,908 | $2,455,113 | $4,076,530 |
| **Operating Income (EBITDA)** | -$367,509 | $427,030 | $2,878,519 |
| **Operating Margin %** | -35.3% | 7.9% | 21.9% |

### Growth Metrics

| Metric | Value |
|--------|-------|
| Y1‚ÜíY2 Revenue Growth | 422% |
| Y2‚ÜíY3 Revenue Growth | 142% |
| 3-Year CAGR | 256% |

---

## 3. Cash Flow Analysis

### Key Cash Metrics

| Metric | Value |
|--------|-------|
| Starting Capital | $500,000 |
| Minimum Cash Position | $86,681 (Month 12) |
| Year 1 Ending Cash | $86,681 |
| Year 2 Ending Cash | $408,606 |
| Year 3 Ending Cash | $3,108,226 |

### Funding Requirements

| Scenario | Amount |
|----------|--------|
| Minimum Funding Required | $613,319 |
| Recommended Initial Raise | $700,000 - $900,000 |

---

## 4. Sensitivity Analysis

### Scenario Comparison

| Metric | Worst Case Y3 | Base Case Y3 | Best Case Y3 |
|--------|---------------|--------------|--------------|
| **Customers** | 60,000 | 100,000 | 140,000 |
| **Revenue** | $6.40M | $13.16M | $22.30M |
| **Gross Profit** | $3.07M | $6.96M | $13.09M |
| **Gross Margin** | 48.0% | 52.8% | 58.7% |
| **EBITDA** | -$881K | $2.88M | $9.12M |
| **EBITDA Margin** | -13.8% | 21.9% | 40.9% |

### Key Risk Factors
- Customer acquisition 40% harder ‚Üí EBITDA cut by ~50%
- Higher churn (22.5% vs 15%) significantly impacts LTV
- COGS increases reduce gross margin by 5-7 points

### Key Upside Drivers
- 40% more customers with 25% lower CAC ‚Üí 2.5x+ EBITDA improvement
- Scale economies reducing COGS by 10%
- Lower churn improving subscription retention

---

## 5. Path to Profitability

### Timeline

| Phase | Period | Status |
|-------|--------|--------|
| Investment Phase | Months 1-12 (Y1) | Building customer base |
| Transition | Q1-Q2 (Y2) | Approaching breakeven |
| Profitable | Q2 onwards (Y2) | Consistently profitable |

### Breakeven Analysis

- **Expected Breakeven:** Q2 Year 2 (Month 15-18)
- **First Profitable Quarter:** Q1 Year 2 with $28,608 EBITDA
- **First Profitable Year:** Year 2 with $427,030 EBITDA (7.9% margin)

### Profitability Milestones

| Milestone | Revenue | EBITDA | Status |
|-----------|---------|--------|--------|
| Month 6 (Y1) | $64K | -$32K | Investing |
| Month 12 (Y1) | $198K | -$21K | Near breakeven |
| Q2 Year 2 | $1.19M | $100K | üü¢ Profitable |
| Year 2 Full | $5.43M | $427K | üü¢ Profitable |
| Year 3 Full | $13.16M | $2.88M | üü¢ Strongly profitable |

---

## 6. Operating Expenses

### Monthly Fixed OpEx (Year 1)

| Category | Monthly Cost |
|----------|--------------|
| Team Salaries | $30,500 |
| Software Subscriptions | $2,500 |
| Office/Coworking | $1,500 |
| Insurance | $800 |
| Legal/Accounting | $2,000 |
| Miscellaneous | $1,200 |
| **Total Monthly** | **$38,500** |
| **Total Annual** | **$462,000** |

### Marketing Spend as % of Revenue

| Year | Marketing % |
|------|-------------|
| Year 1 | 45% |
| Year 2 | 35% |
| Year 3 | 25% |

---

## 7. Key Assumptions

### Pricing
- MSRP: $54.00 per unit (30-day supply)
- Subscription discount: 18%
- Subscription mix increases from 60% (Y1) to 75% (Y3)

### Unit Economics
- Total COGS: $21.12 per unit (39.1% of MSRP)
- Target landed cost: 20-25% achieved at scale

### Customer Metrics
- Monthly churn rate: 15%
- Average subscription length: 4.5 months
- LTV:CAC target: 3:1+ (achieving 4.35x in Y1)

### Growth Targets
- Year 1: 10,000 unique customers
- Year 2: 40,000 unique customers
- Year 3: 100,000 unique customers

---

## 8. Investment Highlights

### Strengths
‚úÖ Strong unit economics with 4.35x LTV:CAC ratio
‚úÖ Fast CAC payback (2 months)
‚úÖ Healthy gross margins (52-54%)
‚úÖ Clear path to profitability (Q2 Y2)
‚úÖ Strong growth trajectory (256% 3-year CAGR)

### Risks
‚ö†Ô∏è Year 1 cash intensive - requires $600-900K funding
‚ö†Ô∏è Customer acquisition costs may increase with scale
‚ö†Ô∏è Subscription churn (15%) requires continuous new customer acquisition
‚ö†Ô∏è Competitive supplement market

### Funding Recommendation
**Raise:** $700,000 - $900,000
- Provides 18-24 month runway
- Covers investment phase through profitability
- Allows for contingency buffer

---

## Appendix: Detailed Monthly P&L (Year 1)

| Month | New Cust | Unique Cust | Active Subs | Orders | Revenue | Gross Profit | EBITDA |
|-------|----------|-------------|-------------|--------|---------|--------------|--------|
| 1 | 45 | 45 | 27 | 45 | $2,168 | $1,217 | -$38,258 |
| 2 | 136 | 181 | 104 | 159 | $7,575 | $4,217 | -$37,692 |
| 3 | 272 | 453 | 252 | 361 | $17,045 | $9,420 | -$36,750 |
| 4 | 454 | 907 | 487 | 669 | $31,392 | $17,263 | -$35,363 |
| 5 | 590 | 1,497 | 768 | 1,004 | $46,751 | $25,547 | -$33,991 |
| 6 | 727 | 2,224 | 1,089 | 1,380 | $63,935 | $34,789 | -$32,481 |
| 7 | 909 | 3,133 | 1,471 | 1,835 | $84,792 | $46,037 | -$30,620 |
| 8 | 1,090 | 4,223 | 1,905 | 2,341 | $107,897 | $58,455 | -$28,598 |
| 9 | 1,272 | 5,495 | 2,383 | 2,892 | $133,005 | $71,926 | -$26,426 |
| 10 | 1,454 | 6,949 | 2,898 | 3,480 | $159,751 | $86,254 | -$24,134 |
| 11 | 1,636 | 8,585 | 3,445 | 4,100 | $187,915 | $101,323 | -$21,739 |
| 12 | 1,409 | 9,994 | 3,774 | 4,338 | $197,569 | $105,950 | -$21,456 |

---

*Financial Model Generated: 2026-01-29
*For: Liposomal Magnesium L-Threonate DTC Brand
*Contact: [Financial Modeling Team]*
